Recent Findings in Solid Cancer Described by Researchers from Memorial Sloan-Kettering Cancer Center (A Phase I, First-in-human Trial of Ko-947, an Erk1/2 Inhibitor, In Patients With Advanced Solid Tumors)

Media coverage

• Title	Recent Findings in Solid Cancer Described by Researchers from Memorial Sloan-Kettering Cancer Center (A Phase I, First-in-human Trial of Ko-947, an Erk1/2 Inhibitor, In Patients With Advanced Solid Tumors)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	03/24/25
  Persons	Anthony J. Olszanski